“…In 2014, the total commercial production of Chinese mitten crab has reached at about 800,000 MT/year exceeding 5.5 billion USD in value (FAO ; Yuan, Wang, Zhang, Li, & Liu, ). Because of their high value, the species has been receiving significant attention to investigate various aspects of physiology and genetics (He et al., ), nutritional requirement (Pan, Xiao, Zhang, & Luan, ), digestible protein‐to‐energy ratio (DP:DE) (Cui et al., ; Li, Li, Liu, & Murphy, ), water temperature (Yuan et al., ) and the effects of various macro‐ and micronutrients such as phospholipid, cholesterol, vitamins and long‐chain fatty acids on production performance (Sui, Wille, Cheng, & Sorgeloos, ; Sun, Chen, Chen, Jiang, & Li, ; Sun et al., ; Tao et al., ; Wang et al., ; Wei et al., ; Wu et al., ). Recently, there is some focus on disease and immune enhancement of the species under farmed conditions (Ding et al., ; Wang et al., ).…”